Frederick M. Abbott

Frederick M. Abbott
Florida State University
College of Law
Damon House, Room 203
Phone: 850.644.1572
Fax: 917.591.3112
fabbott@law.fsu.edu
LL.M., University of California at Berkeley, 1989
J.D., Yale University, 1977
B.A., University of California at Berkeley, 1974
Frederick Abbott is the Edward Ball Eminent Scholar Professor of Law. He is highly regarded for his scholarship and professional activities primarily focused on intellectual property (U.S. and international), international trade, public health and competition/antitrust. He has served as expert consultant and legal advisor for a range of international organizations, regional and national governments, and for non-governmental organizations. He has represented governments in international dispute settlement proceedings. He serves as a dispute settlement panelist for the World Intellectual Property Organization (WIPO) Arbitration and Mediation Center (since 2000), he is on the panel of arbitrators for the EU-Cariforum Economic Partnership, for the South China International Arbitration Center (Hong Kong-SCHIAK) and for the Shenzhen Court of International Arbitration (SCIA). He is on the Editorial Board of the WIPO-WTO Colloquium Series, and he served on the Editorial Board of Oxford’s Journal of International Economic Law from 1998 to 2023. He is currently Co-Chair of the Global Health Law Committee of the International Law Association, having served as Rapporteur for the Committee on International Trade Law from 1993 to 2014.
In 1977, Prof. Abbott began his professional career in the San Francisco Bay Area (Pillsbury Winston Shaw Pittman) representing clients in their international operations and working to establish a Silicon Valley branch where he specialized in technology licensing. From a partnership in that firm, in 1990 he entered academia. He has since been involved in a wide range of activities to promote the development of new technologies and technology licensing, particularly for the health sector. At the request of the WIPO Global Challenges Division, he recently authored an in-depth study of the role played by intellectual property and technology transfer in addressing the COVID-19 pandemic. He was on the founding intellectual property advisory groups for the Drugs for Neglected Diseases initiative (DNDi) and the Foundation for New Innovative Diagnostics (FIND). He has worked on various projects for the WHO directed toward improving pharmaceutical manufacturing.
Prof. Abbott is active in research and teaching in the field of international trade, including as author of books addressing the NAFTA (now USMCA), as well as China’s role in the international trading system. He continues these activities as trade relations evolve, and as security and strategic interests have become more important in defining trade relations.
Prof. Abbott is the author and editor of numerous publications. Books include F. Abbott, et al. International Intellectual Property in an Integrated World Economy (5th ed. 2024)(Aspen), Emerging Markets and the World Patent Order (ed. with C. Correa and P. Drahos) (Elgar 2013), Global Pharmaceutical Policy (with Graham Dukes)(Elgar 2009), The International Intellectual Property System (with T. Cottier & F. Gurry)(1999)(Kluwer), China in the World Trading System (ed. 1998)(Kluwer), Public Policy and Global Technological Integration (ed. with D. Gerber) (1997)(Kluwer), Resource Book on TRIPS and Development (principal consultant with C. Correa (1995))(UNCTAD-ICTSD) and Law and Policy of Regional Integration (1995)(Martinus Nijhoff). His book co-edited with Stefan Riesenfeld, Parliamentary Participation in the Making and Operation of Treaties (1994), was awarded the 1995 American Society of International Law Certificate of Merit for Technical Craftsmanship.
Prof. Abbott has served as Visiting Professor at the University of California at Berkeley School of Law, as Jean Monnet Professor at the University of Bonn, as Visiting Professor and Weickart Fellow at the University of Bern, as Visiting Professor at University of California College of Law, San Francisco and at Vanderbilt Law School. He was a Professor at Chicago-Kent College of Law.
Professor Abbott has taught on the faculty of the World Trade Institute in Bern and in the Executive Course program of the Graduate Institute | Geneva.
Select Recent and Forthcoming Publications
Law and Policy of Pharmaceuticals and Health (Edward Elgar) (forthcoming 2025/6)
International Intellectual Property in an Integrated World Economy (with co-authors) (5th ed., Aspen Publishers 2024)
The State of Intellectual Property and International Law, in New Trends in International Law 415-28, ed. C-J Cheng (Brill | Nijhoff 2024)
Managed Trade and Technology Protectionism: A Formula for Perpetuating Inequality? in Intellectual Property, Innovation and Economic Inequality, eds. D. Benoliel, et al. 305-323, (Cambridge 2024)
Intellectual Property and Technology Transfer for COVID-19 Vaccines: Assessment of the Record, (World Intellectual Property Organization, Geneva) (2023)
Prosecuting Excessive Pricing of Pharmaceuticals under Competition Law: Evolutionary Development, 24 Colum. Sci. & Tech. L. Rev. 173 (2023)
Using Competition Law to Promote Access to Health Technologies: A Supplement to the Guidebook for Low- and Middle-Income Countries (UNDP Publications) (2022)
Excessive Pricing Doctrine in the Pharmaceutical Sector: The Space for Reform, in EU Competition Law and Pharmaceuticals, (W. Sauter, M. Canoy and J. Mulder, editors), (Edward Elgar) (forthcoming 2022)
Technology Governance in a Devolved Global Legal Order: lessons from the China-USA strategic conflict, in A New Global Economic Order, 197-226, (Chia-Jui Cheng ed.) (Brill/Nijhoff Publishers 2022)
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic, Research Paper 116, South Centre, Geneva (August 2020)
Child-Proofing Global Public Health in Anticipation of Emergency, 20 Wash. U. Global Stud. L. Rev. 583 (2021) (symposium)
Opportunities, Constraints and Critical Supports for Achieving Sustainable Local Pharmaceutical Manufacturing in Africa: With a Focus on the Role of Finance (with R. Abbott, J. Fortunak, P. Gehl Sampath & D. Walwyn,), Final Report, March 18, 2021 (Nova Worldwide)
Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic (with Jerome H. Reichman), 23 J. Int’l Econ. L. 535 (Oxford 2020)